225 related articles for article (PubMed ID: 22990674)
1. Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity.
Rosas LE; Grieves JL; Zaraspe K; La Perle KM; Fu H; McCarty DM
Mol Ther; 2012 Nov; 20(11):2098-110. PubMed ID: 22990674
[TBL] [Abstract][Full Text] [Related]
2. Assessing the potential for AAV vector genotoxicity in a murine model.
Li H; Malani N; Hamilton SR; Schlachterman A; Bussadori G; Edmonson SE; Shah R; Arruda VR; Mingozzi F; Wright JF; Bushman FD; High KA
Blood; 2011 Mar; 117(12):3311-9. PubMed ID: 21106988
[TBL] [Abstract][Full Text] [Related]
3. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo.
Nakai H; Yant SR; Storm TA; Fuess S; Meuse L; Kay MA
J Virol; 2001 Aug; 75(15):6969-76. PubMed ID: 11435577
[TBL] [Abstract][Full Text] [Related]
4. rAAV-mediated tumorigenesis: still unresolved after an AAV assault.
Valdmanis PN; Lisowski L; Kay MA
Mol Ther; 2012 Nov; 20(11):2014-7. PubMed ID: 23131853
[No Abstract] [Full Text] [Related]
5. AAV vector integration sites in mouse hepatocellular carcinoma.
Donsante A; Miller DG; Li Y; Vogler C; Brunt EM; Russell DW; Sands MS
Science; 2007 Jul; 317(5837):477. PubMed ID: 17656716
[TBL] [Abstract][Full Text] [Related]
6. No tumour-initiating risk associated with scAAV transduction in newborn rat liver.
Gauttier V; Pichard V; Aubert D; Kaeppel C; Schmidt M; Ferry N; Conchon S
Gene Ther; 2013 Jul; 20(7):779-84. PubMed ID: 23364314
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of DNA double-strand break repair pathways on single-strand and self-complementary adeno-associated virus vector genomes.
Cataldi MP; McCarty DM
J Virol; 2010 Sep; 84(17):8673-82. PubMed ID: 20538857
[TBL] [Abstract][Full Text] [Related]
8. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity.
Wu J; Zhao W; Zhong L; Han Z; Li B; Ma W; Weigel-Kelley KA; Warrington KH; Srivastava A
Hum Gene Ther; 2007 Feb; 18(2):171-82. PubMed ID: 17328683
[TBL] [Abstract][Full Text] [Related]
9. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
10. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis.
McCarty DM; Monahan PE; Samulski RJ
Gene Ther; 2001 Aug; 8(16):1248-54. PubMed ID: 11509958
[TBL] [Abstract][Full Text] [Related]
11. Host cell DNA repair pathways in adeno-associated viral genome processing.
Choi VW; McCarty DM; Samulski RJ
J Virol; 2006 Nov; 80(21):10346-56. PubMed ID: 17041215
[TBL] [Abstract][Full Text] [Related]
12. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver.
Nakai H; Wu X; Fuess S; Storm TA; Munroe D; Montini E; Burgess SM; Grompe M; Kay MA
J Virol; 2005 Mar; 79(6):3606-14. PubMed ID: 15731255
[TBL] [Abstract][Full Text] [Related]
13. Ocular gene transfer with self-complementary AAV vectors.
Yokoi K; Kachi S; Zhang HS; Gregory PD; Spratt SK; Samulski RJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3324-8. PubMed ID: 17591905
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the state of the science for adeno-associated virus integration: An integrated perspective.
Sabatino DE; Bushman FD; Chandler RJ; Crystal RG; Davidson BL; Dolmetsch R; Eggan KC; Gao G; Gil-Farina I; Kay MA; McCarty DM; Montini E; Ndu A; Yuan J;
Mol Ther; 2022 Aug; 30(8):2646-2663. PubMed ID: 35690906
[TBL] [Abstract][Full Text] [Related]
15. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice.
Xu L; Daly T; Gao C; Flotte TR; Song S; Byrne BJ; Sands MS; Parker Ponder K
Hum Gene Ther; 2001 Mar; 12(5):563-73. PubMed ID: 11268288
[TBL] [Abstract][Full Text] [Related]
16. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver.
Nakai H; Iwaki Y; Kay MA; Couto LB
J Virol; 1999 Jul; 73(7):5438-47. PubMed ID: 10364291
[TBL] [Abstract][Full Text] [Related]
17. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver.
Martino AT; Suzuki M; Markusic DM; Zolotukhin I; Ryals RC; Moghimi B; Ertl HC; Muruve DA; Lee B; Herzog RW
Blood; 2011 Jun; 117(24):6459-68. PubMed ID: 21474674
[TBL] [Abstract][Full Text] [Related]
18. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
[TBL] [Abstract][Full Text] [Related]
19. Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents.
Peng D; Qian C; Sun Y; Barajas MA; Prieto J
J Hepatol; 2000 Jun; 32(6):975-85. PubMed ID: 10898318
[TBL] [Abstract][Full Text] [Related]
20. The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis.
Nowrouzi A; Cheung WT; Li T; Zhang X; Arens A; Paruzynski A; Waddington SN; Osejindu E; Reja S; von Kalle C; Wang Y; Al-Allaf F; Gregory L; Themis M; Holder M; Dighe N; Ruthe A; Buckley SM; Bigger B; Montini E; Thrasher AJ; Andrews R; Roberts TP; Newbold RF; Coutelle C; Schmidt M; Themis M
Mol Ther; 2013 Feb; 21(2):324-37. PubMed ID: 23299800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
